KAT2B 抗体 (N-Term)
Quick Overview for KAT2B 抗体 (N-Term) (ABIN6735735)
抗原
See all KAT2B 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
特异性
- Recognizes the N-terminal domain of the transcriptional activator PCAF. This domain of PCAF contains a region that interacts with p300/CBP and it competes with the adenoviral E1A oncoprotein for binding to p300/CBP as a potential tumor suppressor.
-
纯化方法
- Protein G purified
-
免疫原
-
N-terminal domain of human PCAF.
Type of Immunogen: Protein -
亚型
- IgG1
-
-
-
-
应用备注
-
Approved: ELISA (1:8000), WB
Usage: Suitable for use in ELISA, Western Blot. ELISA: 1:8000. -
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- Lot specific
-
缓冲液
- PBS, pH 7.2.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Short term: 4°C
Long term: Add glycerol (40-50%) -20°C.
-
-
- KAT2B (K(lysine) Acetyltransferase 2B (KAT2B))
-
别名
- KAT2B / PCAF
-
背景
-
Name/Gene ID: KAT2B
Synonyms: KAT2B, CREBBP-associated factor, GCN5, Histone acetyltransferase PCAF, K(lysine) acetyltransferase 2B, Lysine acetyltransferase 2B, Histone acetylase PCAF, PCAF, p300/CBP-associated factor, CAF, GCN5L -
基因ID
- 8850
-
UniProt
- Q92831
-
途径
- p53 Pathway, Regulation of Carbohydrate Metabolic Process
抗原
-